On the safety and benefits of repeated intravenous injections of ketamine for depression
P Blier, D Zigman, J Blier - Biological psychiatry, 2012 - biologicalpsychiatryjournal.com
Ketamine is a dissociative anesthetic agent used routinely for more than 40 years in human
anesthesiology (7). It is particularly useful in conditions in which cardiovascular and …
anesthesiology (7). It is particularly useful in conditions in which cardiovascular and …
Has psychiatry tamed the “ketamine tiger?” Considerations on its use for depression and anxiety
KG Rasmussen - Progress in Neuro-Psychopharmacology and …, 2016 - Elsevier
Ketamine has been available for approximately 50 years as an anesthetic agent. It is known
to have potent effects on the central nervous system glutamatergic system, in particular …
to have potent effects on the central nervous system glutamatergic system, in particular …
[HTML][HTML] Ketamine for depression, 1: clinical summary of issues related to efficacy, adverse effects, and mechanism of action
C Andrade - The Journal of clinical psychiatry, 2017 - psychiatrist.com
Ketamine is an anesthetic drug that is also used for off-label indications such as the
mediation of analgesia and sedation in various settings. It is additionally recognized as an …
mediation of analgesia and sedation in various settings. It is additionally recognized as an …
Ketamine for depression: where do we go from here?
Since publication of the first randomized controlled trial describing rapid antidepressant
effects of ketamine, several reports have confirmed the potential utility of this dissociative …
effects of ketamine, several reports have confirmed the potential utility of this dissociative …
Ketamine for depression: where do we go from here?
Since publication of the first randomized controlled trial describing rapid antidepressant
effects of ketamine, several reports have confirmed the potential utility of this dissociative …
effects of ketamine, several reports have confirmed the potential utility of this dissociative …
A word to the wise about ketamine
AF Schatzberg - American Journal of Psychiatry, 2014 - Am Psychiatric Assoc
Recent reports of an acute antidepressant effect for intravenous ketamine, a schedule III
agent used in anesthesia and pain clinics, have generated considerable hope and …
agent used in anesthesia and pain clinics, have generated considerable hope and …
Long-lasting effects of a single subcutaneous dose of ketamine for treating melancholic depression: a case report
V Gálvez, E O'Keefe, L Cotiga… - Biological …, 2014 - biologicalpsychiatryjournal.com
Discussion This is the first trial of ketamine given by the SC route for the treatment of
depression, showing excellent outcomes. In this patient, a single dose of ketamine …
depression, showing excellent outcomes. In this patient, a single dose of ketamine …
[HTML][HTML] Ketamine for depression, 4: in what dose, at what rate, by what route, for how long, and at what frequency?
C Andrade - The Journal of clinical psychiatry, 2017 - psychiatrist.com
Background: Ketamine, administered in subanesthetic doses, is an effective off-label
treatment for severe and even treatment-refractory depression; however, despite dozens of …
treatment for severe and even treatment-refractory depression; however, despite dozens of …
[HTML][HTML] On the safety of repeated ketamine infusions for the treatment of depression: effects of sex and developmental periods
CE Strong, M Kabbaj - Neurobiology of stress, 2018 - Elsevier
In this review, we will discuss the safety of repeated treatments with ketamine for patients
with treatment-resistant depression (TRD), a condition in which patients with major …
with treatment-resistant depression (TRD), a condition in which patients with major …
[HTML][HTML] Oral ketamine for depression, 2: practical considerations
C Andrade - The Journal of clinical psychiatry, 2019 - legacy.psychiatrist.com
The oral route of administration is probably the least expensive and most convenient way to
administer ketamine in indicated contexts in depressed patients. Because only 20%-25% of …
administer ketamine in indicated contexts in depressed patients. Because only 20%-25% of …